Skip to main content
OpenTrials
Completed

NCT Number: NCT04583176

Measurement of Physical Activity in the First Days After Thoracic Surgery

Objective measurement of physical activity has several advantages compared to declarative measures: exemption from memory bias and desirability bias, more precise evaluation, taken into account activities of low intensity, measurement of physical activity and sedentariness profiles (number and duration of periods of activity, number of breaks in sedentary lifestyles).

The aim of this study is to assess the early postoperative mobility of patients who have undergone pulmonary excision by thoracoscopy or robot surgery using ActiGraph GT3X accelerometer. This assessment will serve as a reference element for further studies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Foch

Suresnes, 92150, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Having to undergo pulmonary excision by thoracoscopy or robotic surgery
  • Accepting to wear a belt fitted with an ActiGraph GT3X accelerometer for a maximum of 5 days post surgery
  • Affiliated to a Health Insurance plan
  • Having given an oral non-opposition

Exclusion criteria

  • Pregnant or breastfeeding woman
  • Patient unable to move independently (paraplegic, etc.)
  • Patient deprived of liberty or under guardianship.

Treatment and study plan

Primary outcomes

  1. Measurement of postoperative mobility during the first postoperative days

    Time frame: Day 5

    Number of steps

Secondary outcomes

  1. Volume of physical activity assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Total activity counts per day

  2. Overall intensity of physical activity assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Steps and counts per hour and per minute

  3. Duration and intensity of physical activity assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Time in physical activity of different intensities

  4. Sedentary time assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Total sedentary time

  5. Best natural effort assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Peak cadence

  6. Patterns of physical activity assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Number and mean duration of bouts of physical activity

  7. Patterns of sedentary behavior assessed by accelerometry during the first postoperative days

    Time frame: Day 5

    Number and mean duration of bouts of sedentary behavior

  8. Physiotherapists' evaluation during the first post-operative days

    Time frame: Day 5

    Daily activity assessment after thoracic surgery Questionnaire

  9. Postoperative analgesia

    Time frame: Day 5

    Daily activity assessment after thoracic surgery Questionnaire

  10. Assessement of patient acceptability for wearing the ActiGraph GT3X

    Time frame: Day 5

    Digital assessment scale

  11. Postoperative complications

    Time frame: Day 5

    Morbidity and Mortality after Thoracic Surgery Classification

Sponsors and collaborators

Lead sponsor

Hopital Foch

Other

Registry information

Acronym: Marchez

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Oct 12, 2020
Registry last updated
Jan 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.